FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

121211000001101: Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16169901000001119 Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16170001000001115 Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Is a Product containing precisely spironolactone 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Has active ingredient Spironolactone false Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Has specific active ingredient Spironolactone true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Is pack of False Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet Has AMP True Spironolactone 50mg tablets (IVAX Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start